BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37454877)

  • 41. Kindlin‑2 promotes clear cell renal cell carcinoma progression through the Wnt signaling pathway.
    Li M; Pei X; Wang G; Zhan J; Du J; Jiang H; Tang Y; Zhang H; He H
    Oncol Rep; 2017 Sep; 38(3):1551-1560. PubMed ID: 28677779
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Elevated Expression of ADAP2 is Associated With Aggressive Behavior of Human Clear-Cell Renal Cell Carcinoma and Poor Patient Survival.
    Qiang Y; Wang X; Ding J; Wang Z; Li B; Ji H; Zhang X; Yang Y; Liu K; Zhang L; Ma S; Zhao D; Lu G
    Clin Genitourin Cancer; 2023 Apr; 21(2):e78-e91. PubMed ID: 36127253
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395.
    Sun G; Zhou H; Chen K; Zeng J; Zhang Y; Yan L; Yao W; Hu J; Wang T; Xing J; Xiao K; Wu L; Ye Z; Xu H
    J Exp Clin Cancer Res; 2020 Jun; 39(1):116. PubMed ID: 32560659
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway.
    Ji SQ; Su XL; Cheng WL; Zhang HJ; Zhao YQ; Han ZX
    Urol Oncol; 2014 Feb; 32(2):153-61. PubMed ID: 23273913
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TAGLN2 Promotes the Proliferation, Migration, Invasion, and EMT of Clear Cell Renal Cell Carcinoma Through the PI3K/Akt Signaling Pathway.
    He Y; Zhang B; Han D; Du Y; Zhang X; Wang H; Yue Z; Shang P
    Biochem Genet; 2023 Aug; 61(4):1265-1281. PubMed ID: 36547768
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alterations in enhancer of zeste homolog 2, matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression are associated with ex vivo and in vitro bone metastasis in renal cell carcinoma.
    Wang J; Ren Y; Guo X; Cheng H; Ye Y; Qi J; Yang C; You H
    Mol Med Rep; 2015 May; 11(5):3585-92. PubMed ID: 25571919
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proteoglycan SPOCK1 as a Poor Prognostic Marker Promotes Malignant Progression of Clear Cell Renal Cell Carcinoma via Triggering the Snail/Slug-MMP-2 Axis-Mediated Epithelial-to-Mesenchymal Transition.
    Lin YW; Wen YC; Hsiao CH; Lai FR; Yang SF; Yang YC; Ho KH; Hsieh FK; Hsiao M; Lee WJ; Chien MH
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766694
    [TBL] [Abstract][Full Text] [Related]  

  • 48. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.
    Chen X; Wang X; Ruan A; Han W; Zhao Y; Lu X; Xiao P; Shi H; Wang R; Chen L; Chen S; Du Q; Yang H; Zhang X
    Clin Cancer Res; 2014 May; 20(10):2617-30. PubMed ID: 24647573
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Silencing of the chemokine CXC receptor 4 (CXCR4) hampers cancer progression and increases cisplatin (DDP)-sensitivity in clear cell renal cell carcinoma (ccRCC).
    Wang W; Gan Z; Liu Q; Yan S; Mulati R; Wang Y
    Bioengineered; 2021 Dec; 12(1):2957-2969. PubMed ID: 34180759
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TOX3 inhibits cancer cell migration and invasion via transcriptional regulation of SNAI1 and SNAI2 in clear cell renal cell carcinoma.
    Jiang B; Chen W; Qin H; Diao W; Li B; Cao W; Zhang Z; Qi W; Gao J; Chen M; Zhao X; Guo H
    Cancer Lett; 2019 May; 449():76-86. PubMed ID: 30772441
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling.
    Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH
    Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173
    [TBL] [Abstract][Full Text] [Related]  

  • 52. RUNX1 predicts poor prognosis and correlates with tumor progression in clear cell renal carcinoma.
    Ma J; He S; Li M; Peng Y; Yang X; Chen L; Jia Q; Liu Y
    Pathol Res Pract; 2023 Nov; 251():154886. PubMed ID: 37844486
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma.
    Zhou J; Deng Z; Chen Y; Gao Y; Wu D; Zhu G; Li L; Song W; Wang X; Wu K; He D
    Urol Oncol; 2015 Mar; 33(3):113.e9-17. PubMed ID: 25192834
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MIOX inhibits autophagy to regulate the ROS -driven inhibition of STAT3/c-Myc-mediated epithelial-mesenchymal transition in clear cell renal cell carcinoma.
    Meng L; Gao J; Mo W; Wang B; Shen H; Cao W; Ding M; Diao W; Chen W; Zhang Q; Shu J; Dai H; Guo H
    Redox Biol; 2023 Dec; 68():102956. PubMed ID: 37977044
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long Non-Coding RNA LOC648987 Promotes Proliferation and Metastasis of Renal Cell Carcinoma by Regulating Epithelial-Mesenchymal Transition.
    Su Y; Zhou L; Yu Q; Lu J; Liu W
    Technol Cancer Res Treat; 2021; 20():1533033821997834. PubMed ID: 33858283
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ubiquitin-specific peptidase 53 inhibits the occurrence and development of clear cell renal cell carcinoma through NF-κB pathway inactivation.
    Gui D; Dong Z; Peng W; Jiang W; Huang G; Liu G; Ye Z; Wang Y; Xu Z; Fu J; Luo S; Zhao Y
    Cancer Med; 2021 Jun; 10(11):3674-3688. PubMed ID: 33973730
    [TBL] [Abstract][Full Text] [Related]  

  • 57. LIMD2 promotes tumor proliferation, invasion, and epithelial-mesenchymal transition in clear cell renal cell carcinoma.
    Zhong QY; Xie YW; Chen ZL; Chen YQ; Liu YX; Xie WL; Yan W
    Neoplasma; 2022 Jul; 69(4):832-840. PubMed ID: 35532296
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exosomal microRNA-15a from ACHN cells aggravates clear cell renal cell carcinoma via the BTG2/PI3K/AKT axis.
    Li DY; Lin FF; Li GP; Zeng FC
    Kaohsiung J Med Sci; 2021 Nov; 37(11):973-982. PubMed ID: 34337864
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 60. NLRC5 mediates cell proliferation, migration, and invasion by regulating the Wnt/β-catenin signalling pathway in clear cell renal cell carcinoma.
    Wang Q; Ding H; He Y; Li X; Cheng Y; Xu Q; Yang Y; Liao G; Meng X; Huang C; Li J
    Cancer Lett; 2019 Mar; 444():9-19. PubMed ID: 30543814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.